ENTRADA THERAPEUTICS INC's ticker is and the CUSIP is 29384C108. A total of 78 filers reported holding ENTRADA THERAPEUTICS INC in Q1 2024. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $7,993,837 | -56.1% | 560,971 | -56.3% | 0.48% | -27.7% |
| Q1 2024 | $18,190,525 | -6.1% | 1,283,735 | 0.0% | 0.67% | -3.6% |
| Q4 2023 | $19,371,561 | -4.5% | 1,283,735 | -0.0% | 0.69% | -28.2% |
| Q3 2023 | $20,287,200 | +2.2% | 1,284,000 | -2.1% | 0.96% | +26.6% |
| Q2 2023 | $19,857,200 | -25.2% | 1,311,572 | -28.4% | 0.76% | -33.9% |
| Q1 2023 | $26,558,316 | +5.9% | 1,831,608 | -1.2% | 1.15% | +12.4% |
| Q4 2022 | $25,067,540 | -18.6% | 1,854,108 | -5.1% | 1.02% | -14.2% |
| Q3 2022 | $30,802,000 | +29.4% | 1,954,419 | 0.0% | 1.20% | +31.5% |
| Q2 2022 | $23,805,000 | +29.7% | 1,954,419 | 0.0% | 0.91% | +58.6% |
| Q1 2022 | $18,352,000 | -45.2% | 1,954,419 | -0.0% | 0.57% | -24.7% |
| Q4 2021 | $33,460,000 | – | 1,954,420 | – | 0.76% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 4,425,784 | $63,067,422 | 34.64% |
| 5AM Venture Management, LLC | 4,408,379 | $62,819,401 | 14.05% |
| StepStone Group LP | 761,277 | $10,848,197 | 2.20% |
| Baker Brothers Advisors | 4,865,819 | $69,337,921 | 0.89% |
| TCG Crossover Management, LLC | 584,955 | $8,335,609 | 0.87% |
| Nan Fung Group Holdings Ltd | 49,082 | $699,419 | 0.75% |
| Redmile Group, LLC | 560,971 | $7,993,837 | 0.48% |
| Corton Capital Inc. | 54,973 | $783,365 | 0.41% |
| CORNERCAP INVESTMENT COUNSEL INC | 13,014 | $185,450 | 0.03% |
| MOORE CAPITAL MANAGEMENT, LP | 105,000 | $1,496,250 | 0.03% |